Management of ulcerative colitis in Taiwan : consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023
|
Hsu-Heng Yen, Jia-Feng Wu, Horng-Yuan Wang, Ting-An Chang, Chung-Hsin Chang, Chen-Wang Chang, Te-Hsin Chao, Jen-Wei Chou, Yenn-Hwei Chou, Chiao-Hsiung Chuang ... [et al.]
|
p. 213-249
|
|
|
|
Management of Crohn’s disease in Taiwan : consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023
|
Jia-Feng Wu, Hsu-Heng Yen, Horng-Yuan Wang, Ting-An Chang, Chung-Hsin Chang, Chen-Wang Chang, Te-Hsin Chao, Jen-Wei Chou, Yenn-Hwei Chou, Chiao-Hsiung Chuang ... [et al.]
|
p. 250-285
|
|
|
|
Diagnostic strategy of irritable bowel syndrome : a low- and middle-income country perspective
|
Amal Arifi Hidayat, Langgeng Agung Waskito, Titong Sugihartono, Hafeza Aftab, Yudith Annisa Ayu Rezkitha, Ratha-korn Vilaichone, Muhammad Miftahussurur
|
p. 286-296
|
|
|
|
Intestinal ultrasound for intestinal Behçet disease reflects endoscopic activity and histopathological findings
|
Katsuki Yaguchi, Reiko Kunisaki, Sho Sato, Kaori Hirai, Misato Izumi, Yoshimi Fukuno, Mami Tanaka, Mai Okazaki, Rongrong Wu, Yurika Nishikawa ... [et al.]
|
p. 297-309
|
|
|
|
Adequacy of sigmoidoscopy as compared to colonoscopy for assessment of disease activity in patients of ulcerative colitis : a prospective study
|
Sameet Tariq Patel, Anuraag Jena, Sanjay Chandnani, Shubham Jain, Pankaj Nawghare, Saurabh Bansal, Harsh Gandhi, Rishikesh Malokar, Jay Chudasama, Prasanta Debnath, Seemily Kahmei, Rima Kamat, Sangeeta Kini, Qais Q Contractor, Pravin M Rathi
|
p. 310-318
|
|
|
|
Association between oral corticosteroid starting dose and the incidence of pneumonia in Japanese patients with ulcerative colitis : a nation-wide claims database study
|
Katsuyoshi Matsuoka, Tomoyuki Inoue, Hiroaki Tsuchiya, Katsumasa Nagano, Toshiyuki Iwahori
|
p. 319-335
|
|
|
|
Effects of COVID-19 vaccines on patient-reported outcomes in patients with inflammatory bowel disease : a multicenter survey study in Korea
|
Jung Hyun Ji, Seung Hwan Shin, Yong Eun Park, Jihye Park, Jae Jun Park, Jae Hee Cheon, Tae Il Kim, Sang-Bum Kang, Sang Hyoung Park, Soo Jung Park, IBD Research Group of the Korean Association for the Study of Intestinal Diseases
|
p. 336-350
|
|
|
|
Ustekinumab for anti-tumor necrosis factor refractory pediatric ulcerative colitis : a promising approach towards endoscopic healing
|
Rahiya Rehman, Muhammad Safwan Riaz, Dyadin Esharif, Phinnara Has, Michael Herzlinger, Jason Shapiro, Shova Subedi
|
p. 351-356
|
|
|
|
Changes in the clinical course and prognosis of ulcerative colitis in Chinese populations : a retrospective cohort study
|
Xinyu Liu, Qingfan Yang, Na Diao, Jian Tang, Zicheng Huang, Xiang Gao, Kang Chao
|
p. 357-368
|
|
|
|
Long-term efficacy and safety of tofacitinib in patients with ulcerative colitis : 3-year results from a real-world study
|
Hiromichi Shimizu, Yuko Aonuma, Shuji Hibiya, Ami Kawamoto, Kento Takenaka, Toshimitsu Fujii, Eiko Saito, Masakazu Nagahori, Kazuo Ohtsuka, Ryuichi Okamoto
|
p. 369-377
|
|
|
|
Live-attenuated vaccination in patients with inflammatory bowel disease while continuing or after elective switch to vedolizumab
|
Hisashi Shiga, Hiroshi Nagai, Yusuke Shimoyama, Takeo Naito, Rintaro Moroi, Yoichi Kakuta, Yoshitaka Kinouchi, Atsushi Masamune
|
p. 378-386
|
|
|
|